Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis

Wendy Xolalpa1, Antonio J Vallecillo, Martha Lara

  • 1Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México, D.F., México.

Proteomics
|September 13, 2007
PubMed

Insights

Mycobacterium tuberculosis binds human plasminogen (Plg) using multiple bacterial proteins. This binding facilitates Plg activation to plasmin (Plm), aiding bacterial invasion and tissue damage in tuberculosis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Tuberculosis Research

Background:

  • Bacterial invasion and virulence are often linked to plasminogen (Plg) binding and activation.
  • Understanding the molecular mechanisms of bacterial interaction with host proteins is crucial for developing anti-virulence strategies.

Purpose of the Study:

  • To identify and characterize plasminogen (Plg)-binding proteins from Mycobacterium tuberculosis.
  • To investigate the role of these proteins in Plg activation and potential contribution to tuberculosis pathogenesis.

Main Methods:

  • Proteomic analysis (ligand blotting, N-terminal sequencing, MS) to identify Plg-binding proteins.
  • ELISA and ligand blotting to confirm binding of Plg to recombinant mycobacterial proteins.
  • Assays to assess Plg activation to plasmin (Plm) by tissue-type Plg activator.

Main Results:

  • Fifteen Mycobacterium tuberculosis proteins, including DnaK, GroES, GlnA1, and Ag85 complex, were identified as Plg binders.
  • Binding of Plg to recombinant proteins (DnaK, GlnA1, Ag85B) was confirmed and shown to involve lysine residues.
  • Bound Plg was activated to Plm by tissue-type Plg activator, with M. tuberculosis soluble extracts enhancing this activation.
  • The protein GlnA1 demonstrated binding to extracellular matrix protein fibronectin.

Conclusions:

  • Mycobacterium tuberculosis possesses multiple plasminogen receptors on its surface.
  • Bacterial Plg binding and subsequent activation to Plm may facilitate bacterial dissemination and tissue degradation in tuberculosis.
  • These findings highlight potential targets for novel anti-tuberculosis therapies aimed at inhibiting bacterial virulence.